Chronic Total Occlusion

Top Story

Hiking and CTO PCI: Lessons Learned

Hiking and CTO PCI: Lessons Learned
Cardiology Today's Intervention, March/April 2019
Emmanouil S. Brilakis, MD, PhD
FDA News

FDA approves stent platform to treat chronic total occlusions

February 26, 2019
Medtronic announced today that the FDA has approved its drug-eluting stent platform for treatment of de novo chronic total occlusion lesions in patients with CAD. The…
In the Journals

Transradial access reduces bleeding in CTO PCI

February 20, 2019
Compared with transfemoral access, transradial access was associated with less major bleeding and similar procedural outcomes in patients undergoing PCI for chronic…
In the Journals

Bivalirudin, heparin equally effective in elderly patients undergoing CTO PCI

February 15, 2019
Among elderly patients at high bleeding risk undergoing PCI for chronic total occlusion, bivalirudin was as safe and effective as unfractionated heparin, researchers…
More Headlines »
Meeting News

VIDEO: Intervention highlights from ACC

April 5, 2017
More »
CTO Corner

CTO Education: Planning for 2019

Cardiology Today's Intervention, September/October 2018
Emmanouil S. Brilakis, MD, PhD
Chronic total occlusion PCI continues to rapidly evolve. One of the best ways to keep up — or go ahead —…
More »